iRhythm/IRTC

$112.09

-0.02%
-
1D1W1MYTD1YMAX

About iRhythm

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.

Ticker

IRTC

Sector

Healthcare

Trading on

NASDAQ

Industry

Healthcare Facilities

CEO

Quentin Blackford

Employees

2,000

Headquarters

San francisco, United States

iRhythm Metrics

BasicAdvanced
$3.47B
Market cap
-
P/E ratio
-$4.04
EPS
1.31
Beta
-
Dividend rate
$3.47B
1.30615
$140.23
$70.24
446.22K
2.15
2.02
16.635
16.635
-26.91%
-28%
-54.86%
-36.04%
7.042
16.426
16.583
19.9%
-3.82%
22.94%

What the Analysts think about iRhythm

Analyst Ratings

Majority rating from 12 analysts.
Buy

Price Targets

Average projection from 9 analysts.
24.11% upside
High $165.00
Low $132.00
$112.09
Current price
$139.11
Average price target

iRhythm Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-29.13% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$132.5M
6.34%
Net income
$-38.6M
42.44%
Profit margin
-29.13%
33.99%

iRhythm Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 108.26%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$1.29
-$0.61
-$0.89
-$1.26
-
Expected
-$0.90
-$0.78
-$0.66
-$0.61
-$0.98
Surprise
42.9%
-22.03%
35.1%
108.26%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for iRhythm stock?

iRhythm (IRTC) has a market cap of $3.47B as of April 19, 2024.

What is the P/E ratio for iRhythm stock?

The price to earnings (P/E) ratio for iRhythm (IRTC) stock is 0 as of April 19, 2024.

Does iRhythm stock pay dividends?

No, iRhythm (IRTC) stock does not pay dividends to its shareholders as of April 19, 2024.

When is the next iRhythm dividend payment date?

iRhythm (IRTC) stock does not pay dividends to its shareholders.

What is the beta indicator for iRhythm?

iRhythm (IRTC) has a beta rating of 1.31. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the iRhythm stock price target?

The target price for iRhythm (IRTC) stock is $139.11, which is 24.11% above the current price of $112.09. This is an average based on projections from 9 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell iRhythm stock

Buy or sell iRhythm stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing